United States: DEA Issues Statement On Continuing PHE Telehealth Prescribing Flexibilities Beyond May 11 - Manatt, Phelps & Phillips LLP

On May 3, the Drug Enforcement Administration (DEA) issued a statement from Administrator Anne Milgram on COVID-19 telemedicine flexibilities for prescribing controlled substances...